QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

OMER

QT68Omeros Corporation
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
10.28
+0.64+6.64%
OverviewShort InterestFilings
OMERQT68Omeros Corporation·NASDAQ
OverviewShort InterestFilings
10.28+6.64%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E8.05EPS (ttm)
-2.40
Insider Own5.20%
Shs Outstand72.38M
Perf Week0.98%
Market Cap697.70MForward P/E-EPS next Y-0.20Insider Trans1.12%Shs Float-Perf Month-14.12%
Enterprise Value1.01BPEG0.00EPS next Q-0.27Inst Own-Short Float-Perf Quarter-7.55%
Income86.72MP/S70.52EPS this Y102.08%Inst Trans-Short Ratio-Perf Half Y17.22%
Sales9.89MP/B-EPS next Y-493.34%ROA30.11%Short Interest-Perf YTD-40.16%
Book/sh-0.87P/C-EPS next 5Y174.04%ROE-54.39%52W High17.65 -41.76%Perf Year220.25%
Cash/sh1.87P/FCF-EPS past 3/5Y-ROIC-40.60%52W Low2.95 248.47%Perf 3Y-
Dividend Est.-EV/EBITDA10.83Sales past 3/5Y-Gross Margin-12.39%Volatility14.94% 7.93%Perf 5Y-
Dividend TTM-EV/Sales101.73EPS Y/Y TTM40.37%Oper. Margin-1063.86%ATR (14)0.83Perf 10Y-
Dividend Ex-Date-Quick Ratio3.03Sales Y/Y TTM-Profit Margin871.02%RSI (14)44.50Recom2.47
Dividend Gr. 3/5Y-Current Ratio3.03EPS Q/Q62.50%SMA20-0.76%Beta1.70Target Price40.00
Payout0.00%Debt/Eq-4.90Sales Q/Q-SMA50-15.90%Rel Volume1.61Prev Close9.64
Employees202LT Debt/Eq-1.79EarningsAug 13SMA2001.70%Avg Volume1.63MPrice10.28
IPO DateOct 08, 2009Option/ShortYes / YesEPS/Sales Surpr.40.00% 150.00%Net Debt/EBITDA3.32Volume2,631,680Change6.64%
Analyst Ratings
DateActionAnalystRatingTarget
Jan-08-26ReiteratedH.C. WainwrightBuy$20 → $40
Oct-15-25ReiteratedH.C. WainwrightBuy$9.00 → $20
Jun-27-25ReiteratedH.C. WainwrightBuy$9.00
Nov-10-23DowngradeCantor FitzgeraldOverweight → Neutral
Dec-08-22DowngradeUBSBuy → Neutral$2.00
Nov-08-22DowngradeB of A SecuritiesNeutral → Underperform
Jun-08-22DowngradeB of A SecuritiesBuy → Neutral
Oct-08-21DowngradeJP MorganNeutral → Underweight
Oct-04-21DowngradeMaxim GroupBuy → Hold
Mar-23-18DowngradeWedbushOutperform → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue7500
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A000
Gross Profit7300
Selling, General and Administrative Excl. Other734250
Research and Development11081120
Other Operating Expense00-1
Operating Income-111-123-169
Interest Expense27025
Unusual Expense
———
Non-Operating Income (Expense)13-120-11
Net Income Before Taxes-149-3-183
Income Taxes-1220
Consolidated Net Income-137-3-157
Net Income From Continuing Operations-137-5-183
Net Income-137-3-157
EPS (Recurring)-2.40-0.05-2.70
EPS (Basic, Before Extraordinaries)-2.40-0.05-2.70
EPS (Diluted)-2.40-0.05-2.70
EBITDA-122-2-157
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
8.50——
Gross Margin97.33——
Operating Margin-148.00——
Net Margin-182.67——
Shares Outstanding626458
Market Capitalization6371,100—
Operating Lease Expense
———
Insider Trading Volume
$10.98$9.81$8.63$7.45$6.28● Close Price0.00K187.73K375.46K563.19K750.91KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Cable Thomas J.DirectorMay 22 '26Sale11.617,50087,03935,067May 27 12:00 AM
Cable Thomas J.DirectorMay 22 '26Option Exercise10.8415,000162,60042,567May 27 12:00 AM
Demopulos Gregory A MDChairman, CEO & PresidentFeb 18 '26Option Exercise10.27800,0008,216,0001,826,986Feb 20 12:00 AM
Borges David J.VP, Finance & CAOJan 13 '26Option Exercise3.0660,000183,60065,000Jan 14 12:00 AM
Borges David J.VP, Finance & CAOJan 13 '26Sale12.3130,000369,3150Jan 14 12:00 AM
Borges David J.VP, Finance & CAOJan 12 '26Sale12.7230,000381,6000Jan 14 12:00 AM
Demopulos Gregory A MDChairman, CEO & PresidentNov 17 '23Buy1.6815,00025,200123,945Nov 21 12:00 AM
Demopulos Peter A MDDirectorNov 15 '23Buy1.5310,00015,300208,516Nov 17 12:00 AM
HANISH ARNOLD CDirectorMay 22 '23Option Exercise5.3010,00053,0005,000May 23 12:00 AM
HANISH ARNOLD CDirectorMay 22 '23Sale6.465,00032,3000May 23 12:00 AM
Cable Thomas J.DirectorMay 22 '23Option Exercise5.3010,00053,00040,067May 23 12:00 AM
Cable Thomas J.DirectorMay 22 '23Sale6.535,00032,65035,067May 23 12:00 AM
HANISH ARNOLD CDirectorSep 08 '21Option Exercise9.4420,000188,80010,000Sep 09 12:00 AM
Demopulos Gregory A MDCHAIRMAN, CEO & PRESIDENTJun 17 '21Option Exercise4.1073,714302,2282,063,843Jun 17 12:00 AM
Demopulos Gregory A MDCHAIRMAN, CEO & PRESIDENTJun 17 '21Sale14.9036,857549,1692,026,986Jun 17 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR